Biopharma & Biotechnology

Biological Research Translating into Therapeutic and Biotechnological Applications

Research at Ben-Gurion University of the Negev spans molecular biology, biochemistry, genetics, and bioengineering, supporting biopharma and biotechnology innovation across discovery, development, and validation stages. University researchers focus on understanding biological mechanisms and translating them into therapeutic, diagnostic, and biotechnological applications.

Through BGN, companies engage with these researchers to explore early-stage discovery, evaluate biological feasibility, and connect academic research with development and commercialization pathways.

Where Academic Research Advances Biopharma and Biotechnology

Academic research at Ben-Gurion University of the Negev advances biopharma and biotechnology by integrating life sciences, engineering approaches, and experimental validation.

Drug discovery and therapeutic development

Research addresses drug discovery and therapeutic development, including target identification, mechanism analysis, and early validation. Biotechnology and Life Sciences research supports translational pathways toward clinical development.

Biological production and bioprocesses

Researchers explore biological production systems, bioprocess optimization, and scalable manufacturing concepts. Bioprocessing technologies support efficiency and reproducibility.

Diagnostics, biomarkers, and molecular analysis

Academic research supports diagnostics and biomarker development through molecular and cellular analysis. Medical and Diagnostic Technologies research enables early detection and precision medicine approaches.

Data-driven biology and computational life sciences

Research integrates data-driven approaches into biological research, including omics analysis and predictive modeling. Machine Learning & AI supports large-scale biological data analysis.

How Companies Work with the University Through BGN

Engagements in the biopharma and biotechnology sector typically focus on applied research and biological validation, supported by BGN through:

Joint research projects addressing biological mechanisms and therapeutic concepts
Access to laboratories, biological platforms, and experimental infrastructure
Research outcomes that may inform drug development, commercialization, or licensing

Frequently asked Questions

The research is conducted by academic researchers at Ben-Gurion University of the Negev. BGN supports engagement, collaboration frameworks, and commercialization processes.

Most collaborations begin at early discovery or proof-of-concept stages, with the potential to progress toward applied development and commercialization.

Yes. Many engagements focus on preclinical research, feasibility studies, and biological validation prior to clinical development.

Yes. Research projects often include access to laboratories, biological models, and experimental platforms for validation.

Working with Ben-Gurion University of the Negev

Organizations operating in biopharma and biotechnology are invited to engage with researchers at Ben-Gurion University of the Negev through BGN.